These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
39 related articles for article (PubMed ID: 2847485)
1. Inhibitory regulations of ohmefentanyl and morphine on postsynaptic dopamine receptors. Yao YH; Chi ZQ Zhongguo Yao Li Xue Bao; 1988 Jan; 9(1):15-8. PubMed ID: 2847485 [No Abstract] [Full Text] [Related]
2. NMDA receptors modulate dopamine loss due to energy impairment in the substantia nigra but not striatum. Zeevalk GD; Manzino L; Sonsalla PK Exp Neurol; 2000 Feb; 161(2):638-46. PubMed ID: 10686083 [TBL] [Abstract][Full Text] [Related]
3. Neurons from substantia nigra increase the efficacy and potency of second messenger arising from striatal astroglia dopamine receptor. Hansson E; Rönnbäck L Glia; 1988; 1(6):393-7. PubMed ID: 2906631 [TBL] [Abstract][Full Text] [Related]
4. [Presynaptic autoregulation of dopamine release]. Zharikova AD; Godukhin OV Fiziol Zh SSSR Im I M Sechenova; 1985 Jan; 71(1):105-12. PubMed ID: 2982672 [TBL] [Abstract][Full Text] [Related]
5. Neuronal links in the CNS: focus on dopaminergic and serotonergic regulation of striatal cholinergic neurons. Garattini S; Consolo S; Ladinski H Pol J Pharmacol Pharm; 1980; 32(2):155-64. PubMed ID: 7454621 [TBL] [Abstract][Full Text] [Related]
6. Alterations in dopamine receptors: effect of lesion and haloperidol treatment. Goldstein M; Lew JY; Asano T; Ueta K Commun Psychopharmacol; 1980; 4(1):21-5. PubMed ID: 6105037 [No Abstract] [Full Text] [Related]
7. Diminished responses of nigral dopaminergic neurons to haloperidol and morphine following lesions in the striatum. Kondo Y; Iwatsubo K Brain Res; 1980 Jan; 181(1):237-40. PubMed ID: 7350960 [No Abstract] [Full Text] [Related]
8. Evidence that systemically administered dopamine antagonists activate dopamine neuron firing primarily by blockade of somatodendritic autoreceptors. Pucak ML; Grace AA J Pharmacol Exp Ther; 1994 Dec; 271(3):1181-92. PubMed ID: 7996424 [TBL] [Abstract][Full Text] [Related]
9. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway. Sonsalla PK; Manzino L; Heikkila RE J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797 [TBL] [Abstract][Full Text] [Related]
10. [Relation between GABAergic and dopaminergic neurons in the basal ganglia]. Kemel ML; Gauchy C; Girault JA; Besson JM; Glowinski J Encephale; 1987 Jul; 13 Spec No():169-71. PubMed ID: 3319524 [No Abstract] [Full Text] [Related]
11. Repeated amphetamine administration: role of forebrain in reduced responsiveness of nigrostriatal dopamine neurons to dopamine agonists. Pitts DK; Kelland MD; Freeman AS; Chiodo LA J Pharmacol Exp Ther; 1993 Feb; 264(2):616-21. PubMed ID: 8094749 [TBL] [Abstract][Full Text] [Related]
13. Degeneration of dopaminergic neurons and free radicals. Possible participation of levodopa. Ogawa N; Edamatsu R; Mizukawa K; Asanuma M; Kohno M; Mori A Adv Neurol; 1993; 60():242-50. PubMed ID: 8380518 [No Abstract] [Full Text] [Related]
18. Cholinergic and dopaminergic modulation of potassium conductances in neostriatal neurons. Kitai ST; Surmeier DJ Adv Neurol; 1993; 60():40-52. PubMed ID: 8380527 [TBL] [Abstract][Full Text] [Related]
19. Neurophysiological investigation of effects of the D-1 agonist SKF 38393 on tonic activity of substantia nigra dopamine neurons. Carlson JH; Bergstrom DA; Weick BG; Walters JR Synapse; 1987; 1(5):411-6. PubMed ID: 2975067 [TBL] [Abstract][Full Text] [Related]